Bradley Hargreaves
Chief Operating Officer en XC Velle Institute, Inc. .
Fortuna: 160 256 $ al 31/03/2024
Perfil
Bradley Hargreaves is currently the Operations Director & Principal at XC Velle Institute, Inc. and the Director, VP-Technology & Operations at Cell MedX (Canada) Corp.
He previously worked as the Director at Cell MedX Corp.
from 2023 to 2024.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CELL MEDX CORP.
1.81% | 07/02/2024 | 5 341 855 ( 1.81% ) | 160 256 $ | 31/03/2024 |
Cargos activos de Bradley Hargreaves
| Empresas | Cargo | Inicio |
|---|---|---|
| XC Velle Institute, Inc. | Chief Operating Officer | 01/01/2009 |
Cell MedX (Canada) Corp.
 Cell MedX (Canada) Corp. Pharmaceuticals: MajorHealth Technology Part of Cell MedX Corp., Cell MedX (Canada) Corp. is a Canadian pharmaceutical company. The private company is based in Vancouver, Canada. The CEO of the company is Frank E. Mcenulty. | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Bradley Hargreaves.
| Empresas | Cargo | Fin |
|---|---|---|
| CELL MEDX CORP. | Chief Tech/Sci/R&D Officer | 12/12/2023 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
| Cell MedX Corp. | |
| XC Velle Institute, Inc. | |
Cell MedX (Canada) Corp.
Cell MedX (Canada) Corp. Pharmaceuticals: MajorHealth Technology Part of Cell MedX Corp., Cell MedX (Canada) Corp. is a Canadian pharmaceutical company. The private company is based in Vancouver, Canada. The CEO of the company is Frank E. Mcenulty. | Health Technology |
- Bolsa de valores
- Insiders
- Bradley Hargreaves
